Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.56 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | CTSK | P43235 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10772690 | 0.94 | FAAH (0.64) | FAAHCNR1CNR2CA1ALDH1A1 | |
| SCHEMBL7223847 | 0.92 | FAAH (0.67) | FAAHCNR1CNR2ALDH1A1LMNA | |
| SCHEMBL2363284 | 0.92 | FAAH (0.67) | FAAHCNR1CNR2ALDH1A1LMNA | |
| SCHEMBL19687794 | 0.92 | FAAH (0.67) | FAAHCNR1CNR2ALDH1A1LMNA | |
| SCHEMBL14296416 | 0.86 | FAAH (0.46) | FAAHCNR1CNR2CA2CA1 | |
| SCHEMBL880134 | 0.86 | FAAH (0.46) | FAAHCNR1CNR2CA2CA1 | |
| SCHEMBL14296417 | 0.86 | FAAH (0.46) | FAAHCNR1CNR2CA2CA1 | |
| SCHEMBL4838991 | 0.85 | FAAH (0.54) | FAAHCNR1CNR2CA2CA1 | |
| SCHEMBL3223549 | 0.85 | FAAH (0.54) | FAAHCNR1CNR2CA2CA1 | |
| SCHEMBL18597140 | 0.85 | FAAH (0.54) | FAAHCNR1CNR2CA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110981873-B | Preparation method for synthesizing pyrroloquinoline quinone by five-step method | 江西农业大学 | 2025-01-24 | — | — | CN | claimed |
| CN-110981873-B | Preparation method for synthesizing pyrroloquinoline quinone by five-step method | 江西农业大学 | 2025-01-24 | — | — | CN | disclosed |
| US-20170196848-A1 | Prodrugs of NH-Acidic Compounds: Ester, Carbonate, Carbamate and Phosphonate Derivatives | ALKERMES PHARMA IRELAND LTD (IE) | 2017-07-13 | — | — | US | disclosed |
| US-20170196848-A1 | Prodrugs of NH-Acidic Compounds: Ester, Carbonate, Carbamate and Phosphonate Derivatives | ALKERMES PHARMA IRELAND LTD (IE) | 2017-07-13 | — | — | US | disclosed |
| US-9585965-B2 | Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives | ALKERMES PHARMA IRELAND LIMITED (IE) | 2017-03-07 | — | — | US | disclosed |
| US-20150320875-A1 | Prodrugs of NH-Acidic Compounds: Ester, Carbonate, Carbamate and Phosphonate Derivatives | ALKERMES PHARMA IRELAND LTD (IE) | 2015-11-12 | — | — | US | disclosed |
| US-9072788-B2 | Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives | ALKERMES PHARMA IRELAND LIMITED (IE) | 2015-07-07 | — | — | US | disclosed |
| EP-2358345-B1 | COSMETIC METHOD USING A COMPOSITION CONTAINING SILOXANE RESINS AND A POWDER DYE | ORÉAL L (FR) | 2015-04-08 | — | — | EP | disclosed |
| EP-2358347-B1 | COSMETIC METHOD USING A COMPOSITION CONTAINING SILOXANE RESINS AND A NON-IONIC SILICONE SURFACTANT | OREAL (FR) | 2014-02-26 | — | — | EP | disclosed |
| US-20110319422-A1 | PRODRUGS OF NH-ACIDIC COMPOUNDS: ESTER, CARBONATE, CARBAMATE AND PHOSPHONATE DERIVATIVES | ALKERMES, INC. (US) | 2011-12-29 | — | — | US | disclosed |
| WO-2010063955-A2 | COSMETIC METHOD USING A COMPOSITION CONTAINING SILOXANE RESINS AND A NON-VOLATILE OIL | L'OREAL (FR) | 2010-06-10 | — | — | WO | disclosed |
| WO-2010063958-A2 | COSMETIC METHOD USING A COMPOSITION CONTAINING SILOXANE RESINS AND A VOLATILE SOLVENT | L'OREAL (FR) | 2010-06-10 | — | — | WO | disclosed |
| WO-2009080964-A2 | COSMETIC PROCESS USING A COMPOSITION COMPRISING A SILOXANE RESIN AND A NONVOLATILE OIL | L'OREAL (FR) | 2009-07-02 | — | — | WO | disclosed |
| WO-2009080952-A2 | COSMETIC MAKE-UP AND/OR CARE METHOD USING A SILOXANE RESIN AND A NON-VOLATILE OIL | L'OREAL (FR) | 2009-07-02 | — | — | WO | disclosed |
| US-20090062358-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS | CANO IVAN COLLADO | 2009-03-05 | — | — | US | disclosed |
| EP-1335908-B1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS | LILLY CO ELI (US) | 2008-02-13 | — | — | EP | disclosed |
| US-7304062-B2 | Peroxisome proliferator activated receptor alpha agonists | ELI LILLY AND COMPANY (US) | 2007-12-04 | — | — | US | disclosed |
| US-20040102500-A1 | Peroxisome proliferator activated receptor alpha agonists | CANO IVAN COLLADO (ES) | 2004-05-27 | — | — | US | disclosed |
| EP-1335908-A2 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS | ELI LILLY AND COMPANY (US) | 2003-08-20 | — | — | EP | disclosed |
| WO-2002038553-A2 | TRIAZOLE DERIVATIVES AND THEIR USE AS PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS | ELI LILLY AND COMPANY (US) | 2002-05-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040102500-A1 | Peroxisome proliferator activated receptor alpha agonists | PPARG, PPARA, PPARD | FAAH 368/4885CNR1 4/4885CNR2 5/4885 |
| US-20150320875-A1 | Prodrugs of NH-Acidic Compounds: Ester, Carbonate, Carbamate and Phosphonate Derivatives | PHPT1, SI, CA6 | FAAH 807/4885CNR1 280/4885CNR2 263/4885 |
| US-20170196848-A1 | Prodrugs of NH-Acidic Compounds: Ester, Carbonate, Carbamate and Phosphonate Derivatives | PHPT1, SI, CA6 | FAAH 807/4885CNR1 280/4885CNR2 263/4885 |
| US-20110319422-A1 | PRODRUGS OF NH-ACIDIC COMPOUNDS: ESTER, CARBONATE, CARBAMATE AND PHOSPHONATE DERIVATIVES | PHPT1, SI, CA6 | FAAH 807/4885CNR1 280/4885CNR2 263/4885 |
| US-20090062358-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS | PPARG, PPARA, PPARD | FAAH 81/4885CNR1 6/4885CNR2 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.